Bernstein SocGen cuts Freeport-McMoRan stock price target on Grasberg By Investing.com

Freeport-McMoRan faced a wave of analyst target cuts after a major negative revision to Grasberg recovery pace, with Bernstein SocGen trimming its target to $53.50 from $54 and lowering 2027 EBITDA by about 8%. The company cut 2026 and 2027 copper guidance by roughly 20% and gold guidance by a similar amount, though Q1 2026 results still beat estimates with EPS of $0.57 versus $0.47 expected and revenue of $6.23 billion versus $5.7 billion expected. Shares fell 13% on the guidance shock despite the earnings beat, and analysts cited slower production ramp-up and higher costs at Grasberg.

Analysis

The market is repricing FCX from a ‘scarcity optionality’ story into a more conventional asset-quality debate. The important second-order effect is not just lower unit output, but a higher discount rate on the Grasberg complex itself: if investors now assume slower ramp and repeated operational slippage, the embedded value of future copper leverage gets haircut twice — once through EBITDA and again through multiple compression. That makes FCX more vulnerable than peers to any further negative production surprise over the next 1-2 quarters, even if copper prices stay firm.

The real winner here is not an obvious competitor in the same asset class, but the broader copper basket outside Grasberg exposure. Producers with cleaner ramp visibility and less jurisdictional/operational complexity should see relative inflows as generalist money rotates from idiosyncratic risk to simpler exposure. Downstream, smelters and copper consumers may welcome a softer medium-term supply outlook only if this does not coincide with broader macro weakness; otherwise, the supply shock can still lift refined copper premia and preserve price support for better-positioned miners.

The selloff may be partially overdone in the very short term because consensus had already been leaning on a strong operating cadence and the stock had become crowded with momentum and commodity-beta owners. But the key risk is that the current estimate reset could prove incomplete if recovery timing slips again; the next catalyst window is the next operating update, not the next quarterly print. If management can show stabilization in mine sequencing and costs over the next 30-60 days, some of the multiple damage can reverse; absent that, the stock likely trades as a show-me name for months.

MS looks neutral here, but the mixed analyst reaction reinforces a broader market pattern: high-quality earnings beats are being discounted when guidance credibility deteriorates. That usually favors relative-value trades over outright long exposure in the complex.

Key Decisions for Investors

• Short FCX tactically for 2-6 weeks on rebounds toward pre-gap levels; risk/reward favors a retest lower if the market re-focuses on guidance credibility rather than the earnings beat.
• Pair trade: long a lower-risk copper producer basket vs short FCX for 1-3 months to isolate operational execution risk from copper price exposure; this should work if investors continue rotating toward cleaner assets.
• Sell FCX upside calls or run a call spread overlay into the next operating update; implied volatility should stay elevated while the market prices recurrence risk, limiting upside unless management materially de-risks Grasberg.
• If already long FCX, reduce size by 25-50% and re-enter only after evidence of stable recovery sequencing; the path-dependent risk is more important than near-term commodity direction.
• Watch for a copper price breakout as a hedge, not a thesis driver; if copper rallies while FCX lags, the relative underperformance strengthens the short case rather than invalidating it.